These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10801180)

  • 1. FDA approves first drug in new class of antibiotics.
    Senior K
    Lancet; 2000 Apr; 355(9214):1523. PubMed ID: 10801180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oxazolidinones. A new anti-infective principle].
    Roloff T; Holtfoht A; Ziegler A; Heinzl S
    Med Monatsschr Pharm; 1999 Dec; 22(12):370-5. PubMed ID: 10628146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibiosis. Therapeutic strategies in intensive care].
    Chirurg; 1999 Nov; 70(11 Suppl):1-8. PubMed ID: 10599516
    [No Abstract]   [Full Text] [Related]  

  • 4. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
    Cornell S
    Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
    [No Abstract]   [Full Text] [Related]  

  • 5. Lomefloxacin reaches U.S. market.
    Clin Pharm; 1992 Jun; 11(6):458, 467. PubMed ID: 1318177
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic available for compassionate use.
    AIDS Patient Care STDS; 1998 Feb; 12(2):150. PubMed ID: 11361920
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug approvals in 2000.
    Wynn RL
    Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
    [No Abstract]   [Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
    Antony SJ; Bitter KM; Moreland T; Raudales F; Diaz-Luna H
    Clin Infect Dis; 1999 Nov; 29(5):1341-2. PubMed ID: 10524997
    [No Abstract]   [Full Text] [Related]  

  • 9. Panel report on the Colloquium on Recent Advances in the Therapy of Infectious Diseases.
    J Am Vet Med Assoc; 1984 Nov; 185(10):1054-6. PubMed ID: 6548995
    [No Abstract]   [Full Text] [Related]  

  • 10. First antibiotic in new class of drugs fights resistant infections.
    FDA Consum; 2000; 34(4):4. PubMed ID: 11924635
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral migraine treatment approved.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470199
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefpodoxime marketing approved by FDA.
    Clin Pharm; 1992 Dec; 11(12):999-1000. PubMed ID: 1286555
    [No Abstract]   [Full Text] [Related]  

  • 13. Steps forward and backward within the fluoroquinolone class.
    Hedge DD
    S D J Med; 2000 Apr; 53(4):137-8. PubMed ID: 10790988
    [No Abstract]   [Full Text] [Related]  

  • 14. New antimicrobial agents approved by the U.S. Food and Drug Administration in 1999 and new indications for previously approved agents.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1114-5. PubMed ID: 10722527
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves first drug in new treatment category.
    AIDS Policy Law; 2003 Mar; 18(6):3. PubMed ID: 12712927
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action].
    Sköld O
    Lakartidningen; 1999 Sep; 96(37):3866-7. PubMed ID: 10522087
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA approves Dalvance to treat skin infections.
    Clin Infect Dis; 2014 Jul; 59(2):i. PubMed ID: 25105184
    [No Abstract]   [Full Text] [Related]  

  • 18. The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents.
    Powers JH; Ross DB; Brittain E; Albrecht R; Goldberger MJ
    Clin Infect Dis; 2002 Mar; 34(6):879-81. PubMed ID: 11850875
    [No Abstract]   [Full Text] [Related]  

  • 19. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA-VMAC calls for increased regulation of new antimicrobials; animal groups question conclusion.
    Nolen S
    J Am Vet Med Assoc; 1999 Mar; 214(6):767, 772. PubMed ID: 10101403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.